Effect of testosterone therapy on lumbar spine and hip mineral density in elderly men

References

• Kaufman M, Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 2005; 26: 833–876
   PubMed Web of Science ®Google Scholar
• Gennari L, Merlotti D, Martini G, Gonneli S, Franci B, Campagna S, Lucani B, Dal Canto N, Valenti R, Gennari C, Nuti R. Longitudinal association between sex hormone levels, bone loss, and bone turnover in elderly men. J Clin Endocrinol Metab 2003; 88: 5327–5333
   PubMed Web of Science ®Google Scholar
• Rochira V, Balestrieri A, Madeo B, Zirilli L, Granata A RM, Carani C. Osteoporosis and male age-related hypogonadism: Role of sex steroids on bone (patho)physiology. Eur J Endocrinol 2006; 154: 175–185
   PubMed Web of Science ®Google Scholar
• Vanderschueren D, Vandenput L, Boonen S, Lindberg M K, Bouillon R, Ohlsson C. Androgens and bone. Endocr Rev 2004; 25: 389–425
   PubMed Web of Science ®Google Scholar
• Falahati-Nini A, Riggs L, Atkinson E J, O'Fallon W M, Eastell R, Khosla S. Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest 2000; 106: 1553–1560
   PubMed Web of Science ®Google Scholar
• Tenover J S. Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab 1992; 75: 1092–1098
   PubMed Web of Science ®Google Scholar
• Snyder P J, Peachey H, Berlin J A, Hannoush P, Haddad G, Dlewati A, Santanna J, Loh L, Lenrow D A, Holmes J H, Kapoor S C, Atkinson L E, Strom B L. Effects of testosterone replacement in hypogonadal men. J Clin Endocrinol Metab 2000; 85: 2670–2677
   PubMed Web of Science ®Google Scholar
• Kenny A M, Prestwood K M, Gruman C A, Marcello K M, Raisz L G. Effect of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels. J Gerontol A Biol Sci Med Sci 2001; 56: M266–272
   PubMed Web of Science ®Google Scholar
• Amory J K, Watts N B, Easley K A, Sutton P R, Anawalt B D, Matsumoto A M, Bremner W J, Tenover J L. Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone. J Clin Endocrinol Metab 2004; 89: 503–510
   PubMed Web of Science ®Google Scholar
• Snyder H PJ, Peachey H, Hannoush P, Berlin J A, Loh L, Holmes J H, Dlewati A, Staley J, Santanna H, Kapoor S C, Attie M F, Haddad J G, Strom B L. Effect of testosterone treatment on bone mineral density in men over 65 years of age. J Clin Endocrinol Metab 1999; 84: 1966–1972
   PubMed Web of Science ®Google Scholar
• Saucedo R, Fonseca M E, Basurto L, Ochoa R, Sánchez M, Zárate A. Decremento en los andrógenos circulantes en el hombre durante la senescencia. Gac Med Mex 2000; 136: 335–339
   Google Scholar
• Ruiz-Argüelles G J, Sanchez-Medal L, Loria A, Piedras J, Cordova M S. Red cell indices in normal adultsresiding at altitudes from sea level to 2670 m. Am J Hematol 1980; 8: 265–267
   PubMedGoogle Scholar
• Bhasin S, Cunningham G R, Hayes F J, Matsumoto A M, Snyder P J, Swerdloff R S, Montori V M. Testosterone therapy in adult men with androgen deficiency syndromes: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2006; 91: 1995–2010
   PubMed Web of Science ®Google Scholar
• Szulc P, Munoz F, Claustrat B, Garnero P, Marchand F. Bioavailable estradiol may be an important determinant of osteoporosis in men: The MINOS study. J Clin Endocrinol Metab 2001; 86: 192–199
   PubMed Web of Science ®Google Scholar
• Mellstrom D, Johnell O, Ljunggren O, Eriksson A L, Lorentzon M, Mallmin H, Holmberg A, Redlund-Johnell I, Orwoll E, Ohlsson C. Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden. J Bone Miner Res 2006; 21: 529–535
   PubMed Web of Science ®Google Scholar
• Behre H M, Kliesch S, Leifke E, Link T M, Nieschlag E. Long-term effect of testosterone therapy on bone mineral density in hypogonadal men. J Clin Endocrinol Metab 1997; 82: 2386–2390
   PubMed Web of Science ®Google Scholar
• Benito M, Gomberg B, Wehrli F W, Weening R H, Zemel B, Wright A C, Song H K, Cucchiara C, Snyder P J. Deterioration of trabecular architecture in hypogonadal men. J Clin Endocrinol Metab 2003; 88: 1497–1502
   Google Scholar
• Wang C, Cunningham G, Dobs A, Iranmanesh A, Matsumoto A M, Snyder P J, Weber T, Berman N, Hull L, Swerdloff R S. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab 2004; 89: 2085–2098
   PubMed Web of Science ®Google Scholar
• Katznelson L, Finkelstein J S, Schoenfeld D A, Rosenthal D J, Anderson E J, Klinbanski A. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab 1996; 81: 4358–4365
   PubMed Web of Science ®Google Scholar
• Duan Y, Tabensky A, DeLuca V, Seeman E. The benefit of hormone replacement therapy on bone mass is greater at the vertebral body than posterior processes or proximal femur. Bone 1997; 21: 447–451
   Google Scholar
• Emmelot-Vonk M H, Verhaar H JJ, Pour H RN, Aleman A, Lock T MT, Bosch J LH, Grobbee D E, van der Schouw I T. Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men. A randomized controlled trial. JAMA 2008; 299: 39–52
   PubMed Web of Science ®Google Scholar
• Tracz M J, Sideras K, Boloña E R, Haddad R M, Kennedy C C, Uraga M V, Caples S M, Edwin P J, Montori V M. Testosterone use in men and its effects on bone health. A systematic review and meta-analysis of randomized placebo-controlled. J Clin Endocrinol Metab 2006; 91: 2011–2016
   PubMed Web of Science ®Google Scholar
• Khosla S, Melton L J, III, Riggs B L. Estrogen and the male skeleton. J Clin Endocrinol Metab 2002; 87: 1443–1450
   PubMed Web of Science ®Google Scholar
• Compston J. Local biosynthesis of sex steroids in bone. J Clin Endocrinol Metab 2002; 87: 5398–5400
   PubMedGoogle Scholar
• Meier C, Liu P Y, Handelsman D J, Seibel M J. Endocrine regulation of bone turnover in men. Clin Endocrinol (Oxf) 2005; 63: 603–613
   Google Scholar
• Proctor D N, Melton L J, Khosla S, Crowson C S, O'Connor M K, Riggs B L. Relative influence of physical activity, muscle mass and strength on bone density. Osteoporosis Int 2000; 11: 944–952
   PubMed Web of Science ®Google Scholar
• Allan C A, McLachlan R I. Age-related changes in testosterone and the role of replacement therapy in older men. Clin Endocrinol (Oxf) 2004; 60: 653–670
   PubMed Web of Science ®Google Scholar
• Kelleher S, Conway A J, Handelsman D J. Blood testosterone threshold for androgen deficiency symptoms. J Clin Endocrinol Metab 2004; 89: 3813–3817
   PubMed Web of Science ®Google Scholar
• Liu P Y, Swerdloff R S, Veldhuis J D. The rationale, efficacy and safety of androgen therapy in older men: Future research and current practice recommendations. J Clin Endocrinol Metab 2004; 89: 4789–4796
   PubMed Web of Science ®Google Scholar